Last Posted: Jul 01, 2020
- Clinical outcomes of a genomic screening program for actionable genetic conditions
AH Buchanan et al, Genetics in Medicine, June 30, 2020 - Can genetic testing help in the management of dyslipidaemias?
Lazarte Julieta et al. Current opinion in lipidology 2020 Jun - Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
Ademi Zanfina et al. Atherosclerosis 2020 May 3041-8 - Familial Hypercholesterolemia and the Founder Effect Among Franco-Americans: A Brief History and Call to Action.
Mszar Reed et al. CJC open 2020 May 2(3) 161-167 - Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Hu Pengwei et al. Circulation 2020 Jun 141(22) 1742-1759 - Familial Hypercholesterolemia: Cardiovascular Risk Stratification and Clinical Management
J Kolominsky et al, ACC, June 1, 2020 - Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
Beheshti Sabina O et al. Journal of the American College of Cardiology 2020 May 75(20) 2553-2566 - Assessment of medical intern's knowledge, awareness and practice of familial hypercholesterolemia at academic institutes in Jeddah, Saudi Arabia.
Alzahrani Sami H et al. Lipids in health and disease 2020 May 19(1) 101 - Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction.
Bogsrud Martin P et al. Journal of clinical lipidology 2020 Apr - Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial.
Dufour Robert et al. Journal of clinical lipidology 13(1) 138-147
.png)
No hay comentarios:
Publicar un comentario